The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth
Open accessAbstract
The design of cancer-targeting particles with precisely tuned physicochemical properties may enhance the delivery of therapeutics and access to pharmacological targets. However, a molecular-level understanding of the interactions driving the fate of nanomedicine in biological systems remains elusive. Here, we show that ultrasmall (<10 nm in diameter) poly(ethylene glycol)-coated silica nanoparticles, functionalized with melanoma-targeting peptides, can induce a form of programmed cell death known as ferroptosis in starved cancer cells and cancer-bearing mice. Tumour xenografts in mice intravenously injected with nanoparticles using a high-dose multiple injection scheme exhibit reduced growth or regression, in a manner that is reversed by the pharmacological inhibitor of ferroptosis, liproxstatin-1. These data demonstrate that ferroptosis can be targeted by ultrasmall silica nanoparticles and may have therapeutic potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“is potentially associated with a consistent release of immunostimulatory DAMPs [540, 541]”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [541]
In the citing paper
“Two elegant studies have shown that the application of nanoparticles to tumor-bearing mice is sufficient to induce clinical remission.”
From “Pumping iron”—how macrophages handle iron at the systemic, microenvironmental, and cellular levels (2017) · cites this paper as [112]
In the citing paper
“One of these papers implicated a direct tumoricidal effect of iron delivered by ultrasmall polyethylene glycol particles and attributed tumor regression to the induction of ferroptosis in malignant cells [112].”
From “Pumping iron”—how macrophages handle iron at the systemic, microenvironmental, and cellular levels (2017) · cites this paper as [112]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
Models for Longitudinal Data: A Generalized Estimating Equation Approach
Zeger, S. L., Liang, K., & Albert, P. S. (1988) · Biometrics · doi:10.2307/2531734 · Cited by 4,505
Methods in Mammalian Autophagy Research
Mizushima, N., Yoshimori, T., & Levine, B. (2010) · Cell · doi:10.1016/j.cell.2010.01.028 · Cited by 4,497
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3064 · Cited by 3,732
Self-citationCepharanthine potently enhances the sensitivity of anticancer agents in K562 cells
Ikeda, R., Che, X., Yamaguchi, T., Ushiyama, M., Zheng, C., Okumura, H., Takeda, Y., Shibayama, Y., Nakamura, K. T., Jeung, H., et al. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00057.x · Cited by 2,268
Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α
He, S., Wang, L., Miao, L., Wang, T., Du, F., Zhao, L., & Wang, X. (2009) · Cell · doi:10.1016/j.cell.2009.05.021 · Cited by 2,214
Glutaminolysis and transferrin regulate ferroptosis
Gao, M., Monian, P., Quadri, N., Ramasamy, R., & Jiang, X. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.011 · Cited by 2,069
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 623
Targeting Ferroptosis against Ischemia/Reperfusion Cardiac Injury
Lillo‐Moya, J., Rojas-Solé, C., Muñoz-Salamanca, D., Panieri, E., Saso, L., & Rodrigo, R. (2021) · Antioxidants · doi:10.3390/antiox10050667 · Cited by 166
Ferroptosis: regulation by competition between NRF2 and BACH1 and propagation of the death signal
Nishizawa, H., Yamanaka, M., & Igarashi, K. (2022) · FEBS Journal · doi:10.1111/febs.16382 · Cited by 164
Wu, L. H., Wen, W., Wang, X., Huang, D., Cao, J., Qi, X., & Shen, S. (2022) · Particle and Fibre Toxicology · doi:10.1186/s12989-022-00465-y · Cited by 170
Golgi stress mediates redox imbalance and ferroptosis in human cells
Alborzinia, H., Ignashkova, T. I., Dejure, F. R., Gendarme, M., Theobald, J., Wölfl, S., Lindemann, R. K., & Reiling, J. H. (2018) · Communications Biology · doi:10.1038/s42003-018-0212-6 · Cited by 163
The pathological features of regulated necrosis
Tonnus, W., Meyer, C., Paliege, A., Belavgeni, A., von Mäßenhausen, A., Bornstein, S. R., Hugo, C., Becker, J. U., & Linkermann, A. (2019) · The Journal of Pathology · doi:10.1002/path.5248 · Cited by 168
Jiang, M., Qiao, M., Zhao, C., Deng, J., Li, X., & Zhou, C. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-341 · Cited by 158
Magtanong, L., & Dixon, S. J. (2018) · Developmental Neuroscience · doi:10.1159/000496922 · Cited by 156
Liang, X., Chen, M., Bhattarai, P., Hameed, S., Tang, Y., & Dai, Z. (2021) · ACS Nano · doi:10.1021/acsnano.1c08108 · Cited by 156
Redox-active nanomaterials for nanomedicine applications
Sims, C. M., Hanna, S. K., Heller, D. A., Horoszko, C. P., Johnson, M. E., Bustos, A. R. M., Reipa, V., Riley, K. R., & Nelson, B. C. (2017) · Nanoscale · doi:10.1039/c7nr05429g · Cited by 155
Sung, S., Su, Y., Cheng, W., Hu, P.-F., Chiang, C., Chen, W., & Hu, S. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b03249 · Cited by 154
Zhang, J., Song, L., Xu, L., Fan, Y., Wang, T., Tian, W., Ju, J., & Xu, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.686726 · Cited by 153
The Warburg effect and glucose-derived cancer theranostics
Tekade, R. K., & Sun, X. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.08.003 · Cited by 151
Targeting Ferroptosis: New Hope for As-Yet-Incurable Diseases
Conrad, M., Lorenz, S., & Proneth, B. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.08.010 · Cited by 155
Self-citationFerroptosis: mechanisms and implications for cancer development and therapy response
dos Santos, A. F., Fazeli, G., da Silva, T. N. X., & Angeli, J. P. F. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.04.005 · Cited by 154
Subcellular Performance of Nanoparticles in Cancer Therapy
Liu, C., Han, Y., Kankala, R. K., Wang, S., & Chen, A. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s226186 · Cited by 157
The emerging role of ferroptosis in female reproductive disorders
Liu, M., Ke-ming, W., & Wu, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115415 · Cited by 156
Chafe, S. C., Vizeacoumar, F. S., Venkateswaran, G., Nemirovsky, O., Awrey, S. J., Brown, W. S., McDonald, P. C., Carta, F., Metcalfe, A. L., Karasinska, J. M., et al. (2021) · Science Advances · doi:10.1126/sciadv.abj0364 · Cited by 144
Zhou, Z., Ni, K., Deng, H., & Chen, X. S. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.006 · Cited by 139
Ferroptosis in Non-Small Cell Lung Cancer: Progression and Therapeutic Potential on It
Zou, J., Wang, L., Tang, H., Liu, X., Peng, F., & Peng, C. Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413335 · Cited by 142
Redox Regulation via Glutaredoxin-1 and Protein S -Glutathionylation
Matsui, R., Ferrán, B., Oh, A., Croteau, D., Shao, D., Han, J., Pimentel, D. R., & Bachschmid, M. M. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7963 · Cited by 142
Zhang, C., Liu, Z., Zhang, Y., Ma, L., Song, E., & Song, Y. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2384-5 · Cited by 140
Vacancies on 2D transition metal dichalcogenides elicit ferroptotic cell death
Xu, S., Zheng, H., Ma, R., Wu, D., Pan, Y., Yin, C., Gao, M., Wang, W., Li, W., Liu, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17300-7 · Cited by 140
Self-citationInduction and application of ferroptosis in cancer therapy
Nie, Q. H., Hu, Y., Yu, X. H., Li, X., & Fang, X. (2022) · Cancer Cell International · doi:10.1186/s12935-021-02366-0 · Cited by 146
Nanoparticles Synergize Ferroptosis and Cuproptosis to Potentiate Cancer Immunotherapy
Li, Y., Liu, J., Chen, Y., Weichselbaum, R. R., & Lin, W. (2024) · Advanced Science · doi:10.1002/advs.202310309 · Cited by 144
Symphony of nanomaterials and immunotherapy based on the cancer–immunity cycle
Li, Q., Shi, Z., Zhang, F., Zeng, W., Zhu, D., & Mei, L. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.031 · Cited by 136
Progress in Understanding Ferroptosis and Challenges in Its Targeting for Therapeutic Benefit
Zou, Y., & Schreiber, S. L. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.03.015 · Cited by 132
Bertrand, R. L. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.02.017 · Cited by 132
Cold stress‐induced ferroptosis involves the ASK1‐p38 pathway
Hattori, K., Ishikawa, H., Sakauchi, C., Takayanagi, S., Naguro, I., & Ichijo, H. (2017) · EMBO Reports · doi:10.15252/embr.201744228 · Cited by 134
Liu, C.-G., Han, Y., Zhang, J.-T., Kankala, R. K., Wang, S., & Chen, A. (2019) · Chemical Engineering Journal · doi:10.1016/j.cej.2019.03.272 · Cited by 133
Decoding ferroptosis for cancer therapy
Wahida, A., & Conrad, M. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00864-1 · Cited by 168
Self-citationSaponin Formosanin C-Induced Ferritinophagy and Ferroptosis in Human Hepatocellular Carcinoma Cells
Lin, P.-L., Tang, H. F., Wu, S., Shaw, N.-S., & Su, C. (2020) · Antioxidants · doi:10.3390/antiox9080682 · Cited by 129
Wang, X., Hua, P., He, C., & Chen, M. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.03.020 · Cited by 131
Novel insights on targeting ferroptosis in cancer therapy
Zuo, S., Yu, J., Pan, H., & Lu, L. (2020) · Biomarker Research · doi:10.1186/s40364-020-00229-w · Cited by 128
Wang, S., Yang, L., Cho, H., Chueng, S. D., Zhang, H., Zhang, Q., & Lee, K. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119498 · Cited by 122
Recent progress on targeting ferroptosis for cancer therapy
Xu, G., Wang, H., Li, X., Huang, R., & Luo, L. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114584 · Cited by 121
Regulatory pathways and drugs associated with ferroptosis in tumors
Wang, D., Tang, L. M., Zhang, Y., Ge, G., Jiang, X., Mo, Y., Wu, P., Deng, X., Li, L., Zuo, S., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04927-1 · Cited by 131
Self-citationZhang, X., Luan, J., Chen, W., Fan, J., Nan, Y., Wang, Y., Liang, Y., Meng, G., & Ju, D. (2018) · Nanoscale · doi:10.1039/c8nr00554k · Cited by 124
Sábio, R. M., Meneguin, A. B., Ribeiro, T. D. C., da Silva, R. R., & Chorilli, M. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.04.067 · Cited by 126
Zhang, H., Wang, T., Qiu, W., Han, Y., Sun, Q., Zeng, J., Yan, F., Zheng, H., Li, Z., & Gao, M. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b01818 · Cited by 121
Self-citationManganese dioxide nanosheets: from preparation to biomedical applications
Wu, M., Hou, P., Dong, L., Cai, L., Chen, Z., Zhao, M., & Li, J. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s207666 · Cited by 121
Yang, H., Yao, X., Liu, Y., Shen, X., Li, M., & Luo, Z. Y. (2023) · ACS Nano · doi:10.1021/acsnano.3c04632 · Cited by 122
Iron and magnetic: new research direction of the ferroptosis-based cancer therapy.
Wang, S., Luo, J., Zhang, Z., Dong, D., Shen, Y., Fang, Y., Hu, L., Liu, M., Dai, C., Peng, S., et al. (2018) · Europe PMC (PubMed Central) · Cited by 117
Ferroptosis: An emerging therapeutic opportunity for cancer
Wang, L., Chen, X., & Yan, C. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.09.005 · Cited by 120
Ferroptosis: Final destination for cancer?
Zeng, Y., Liu, W., Zhuo, Q., Hu, Q., Liu, M., Sun, Q., Zhang, Z., Fan, G., Xu, W., Ji, S., et al. (2020) · Cell Proliferation · doi:10.1111/cpr.12761 · Cited by 116
Research on ferroptosis as a therapeutic target for the treatment of neurodegenerative diseases
Wang, Y., Lv, M.-N., & Zhao, W. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102035 · Cited by 122
Lipid peroxidation regulates long-range wound detection through 5-lipoxygenase in zebrafish
Katikaneni, A., Jelcic, M., Gerlach, G. F., Ma, Y., Overholtzer, M., & Niethammer, P. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0564-2 · Cited by 110
Self-citationGene interfered-ferroptosis therapy for cancers
Gao, J., Luo, T., Wang, J., & Wang, J. (2021) · Nature Communications · doi:10.1038/s41467-021-25632-1 · Cited by 110
von Mäßenhausen, A., Gonzalez, N. Z., Maremonti, F., Belavgeni, A., Tonnus, W., Meyer, C., Beer, K., Hannani, M. T., Lau, A. N., Peitzsch, M., et al. (2022) · Science Advances · doi:10.1126/sciadv.abl8920 · Cited by 110
Developments in nanotechnology approaches for the treatment of solid tumors
Venturini, J., Chakraborty, A., Baysal, M. A., & Tsimberidou, A. M. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00656-1 · Cited by 123
Liu, N., Liang, Y., Wei, T., Zou, L., Huang, X., Kong, L., Tang, M., & Zhang, T. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.129043 · Cited by 106
The role of lysosome in regulated necrosis
Alu, A., Han, X., Ma, X., Wu, M., Wei, Y., & Wei, X. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.07.003 · Cited by 109
Nutritional and Metabolic Control of Ferroptosis
Mishima, E., & Conrad, M. (2022) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-062320-114541 · Cited by 107
Self-citationRegulation of GSK3β/Nrf2 signaling pathway modulated erastin-induced ferroptosis in breast cancer
Wu, X., Liu, C., Li, Z., Gai, C., Ding, D., Chen, W., Hao, F., & Li, W. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03821-8 · Cited by 103
Cancer therapeutic strategies based on metal ions
Liu, Y., Wang, Y., Song, S., & Zhang, H. (2021) · Chemical Science · doi:10.1039/d1sc03516a · Cited by 103
Different modalities of host cell death and their impact on Mycobacterium tuberculosis infection
Nisa, A., Kipper, F. C., Panigrahy, D., Tiwari, S., Kupz, A., & Subbian, S. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00246.2022 · Cited by 102
An Organelle‐Specific Nanozyme for Diabetes Care in Genetically or Diet‐Induced Models
Zhou, Y., Liu, C., Yu, Y., Yin, M., Sun, J., Huang, J., Chen, N., Wang, H., Fan, C., & Song, H. (2020) · Advanced Materials · doi:10.1002/adma.202003708 · Cited by 101
Targeting Lipid Peroxidation for Cancer Treatment
Clemente, S. M., Martínez-Costa, Ó. H., Monsalve, M., & Samhan-Arias, A. K. (2020) · Molecules · doi:10.3390/molecules25215144 · Cited by 100
Nishizawa, H., Matsumoto, M., Chen, G., Ishii, Y., Tada, K., Onodera, M., Kato, H., Muto, A., Tanaka, K., & Igarashi, K. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03613-y · Cited by 103
Ferroptosis‐related gene signature predicts prognosis and immunotherapy in glioma
Wan, R., Wang, P., Xia, Q., Zhou, H., & Mao, X. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13654 · Cited by 100
Magnetic nanoparticles for ferroptosis cancer therapy with diagnostic imaging
Ko, M. J., Min, S., Hong, H., Yoo, W., Joo, J., Zhang, Y. S., Kang, H., & Kim, D. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.09.015 · Cited by 101
Cai, X., Dong, J., Liu, J., Zheng, H., Kaweeteerawat, C., Wang, F., Ji, Z., & Li, R. (2018) · Nature Communications · doi:10.1038/s41467-018-06869-9 · Cited by 97
An, P., Gao, Z., Sun, K., Gu, D., Wu, H., You, C., Li, Y., Cheng, K., Zhang, Y., Wang, Z., et al. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b16124 · Cited by 98
Peng, C., Huang, Y., & Zheng, J. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.03.020 · Cited by 98
Ferroptosis in life: To be or not to be
Xu, L., Liu, Y., Chen, X., Zhong, H., & Wang, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114241 · Cited by 100
Gold/alpha-lactalbumin nanoprobes for the imaging and treatment of breast cancer
Jiang, Y., Wang, T., Zhao, L., Rajasekhar, V. K., Joshi, S., Andreou, C., Pal, S., Hsu, H., Zhang, H., Cohen, I., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0584-z · Cited by 95
Qiu, S., Zhou, Y., Ren, X., Zou, B., Guo, W., Song, L., & Hu, Y. Z. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.126212 · Cited by 94
Advances in Magnetic Nanoparticle‐Mediated Cancer Immune‐Theranostics
Cheng, H., Tsao, H., Chiang, C., & Chen, S. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202001451 · Cited by 98
Emerging role of immunogenic cell death in cancer immunotherapy
Arimoto, K., Miyauchi, S., Liu, M., & Zhang, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1390263 · Cited by 103
Ferroptosis: Biological Rust of Lipid Membranes
Hassannia, B., Coillie, S. V., & Berghe, T. V. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8175 · Cited by 93
Soares, P. I. P., Romão, J., Matos, R. J. R., Silva, J. A. M. D. C., & Borges, J. P. (2020) · Progress in Materials Science · doi:10.1016/j.pmatsci.2020.100742 · Cited by 100
Ferroptosis and Autoimmune Diseases
Lai, B., Wu, C., Wu, C., Luo, S., & Lai, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.916664 · Cited by 95
Liu, Y., Quan, X., Li, J., Huo, J., Li, X., Zhao, Z., Li, S., Wan, J., Li, J., Liu, S., et al. (2022) · National Science Review · doi:10.1093/nsr/nwac167 · Cited by 94
Zheng, H., Wang, S., Zhou, L., He, X., Cheng, Z., Cheng, F., Liu, Z., Wang, X., Chen, Y., & Zhang, Q. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.126439 · Cited by 94
Regulated cell death in cancer: from pathogenesis to treatment
Gong, L., Huang, D., Shi, Y., Liang, Z., & Bu, H. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002239 · Cited by 95
Yan, C., Guo, Z., Shen, Y., Chen, Y., Tian, H., & Zhu, W. (2018) · Chemical Science · doi:10.1039/c8sc01069b · Cited by 91
Yang, B., Liu, Q., Yao, X., Zhang, D., Dai, Z., Cui, P., Zhang, G., Zheng, X., & Yu, D. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b11353 · Cited by 90
Delivering metal ions by nanomaterials: Turning metal ions into drug-like cancer theranostic agents
Liu, C., Guo, L., Wang, Y., Zhang, J., & Fu, C. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215332 · Cited by 90
Oxidative stress modulating nanomaterials and their biochemical roles in nanomedicine
Patel, K. D., Keskin‐Erdogan, Z., Sawadkar, P., Sharifulden, N. S. A. N., Shannon, M. R., Patel, M., Silva, L. V. B., Patel, R., Chau, D. Y. S., Knowles, J. C., et al. (2024) · Nanoscale Horizons · doi:10.1039/d4nh00171k · Cited by 92
Cell death in drug-induced liver injury
Iorga, A., & Dara, L. (2019) · Advances in pharmacology · doi:10.1016/bs.apha.2019.01.006 · Cited by 89
Kumar, P., Tambe, P., Paknikar, K. M., & Gajbhiye, V. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.024 · Cited by 92
Zhang, Y., Li, S., Li, F., Lv, C., & Yang, Q. (2021) · Biology Direct · doi:10.1186/s13062-021-00294-7 · Cited by 85
Xu, Q., Zhang, Y., Yang, Z., Jiang, G., Lv, M., Wang, H., Liu, C., Xie, J., Wang, C., Guo, K., et al. (2022) · Theranostics · doi:10.7150/thno.73039 · Cited by 89
Role of GRP78 inhibiting artesunate-induced ferroptosis in KRAS mutant pancreatic cancer cells
Wang, K., Zhang, Z., Wang, M., Cao, X., Qi, J., Wang, D., Gong, A., & Zhu, H. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s199459 · Cited by 87
Mechano‐Responsive Leapfrog Micelles Enable Interactive Apoptotic and Ferroptotic Cancer Therapy
Li, Y., Qin, Y., Shang, Y., Li, Y., Liu, F., Luo, J., Zhu, J., Guo, X., Wang, Z., & Zhao, Y. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202112000 · Cited by 84
Kuang, Y., & Wang, Q. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.08.007 · Cited by 87
Qin, D., Wang, J., Le, A., Wang, T. J., Chen, X., & Wang, J. (2021) · Cells · doi:10.3390/cells10051009 · Cited by 83
Nanomedicine‐Enabled/Augmented Cell Pyroptosis for Efficient Tumor Nanotherapy
Zhang, Z., Zhou, Y., Zhao, S., Ding, L., Chen, B., & Chen, Y. (2022) · Advanced Science · doi:10.1002/advs.202203583 · Cited by 84
Mechanisms of redox metabolism and cancer cell survival during extracellular matrix detachment
Hawk, M. A., & Schafer, Z. T. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.tm117.000260 · Cited by 82
Zooming in and out of ferroptosis in human disease
Wang, X., Zhou, Y., Min, J., & Wang, F. (2023) · Frontiers of Medicine · doi:10.1007/s11684-023-0992-z · Cited by 85
Magnetic nanoparticles in regenerative medicine: what of their fate and impact in stem cells?
de Walle, A. V., Perez, J. E., Abou‐Hassan, A., Hémadi, M., Luciani, N., & Wilhelm, C. (2020) · Materials Today Nano · doi:10.1016/j.mtnano.2020.100084 · Cited by 83
Photothermal nanozyme-ignited Fenton reaction-independent ferroptosis for breast cancer therapy
Xing, L., Liu, X., Zhou, T., Wan, X., Wang, Y., & Jiang, H. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.09.019 · Cited by 81
Liu, Y., Liu, X., Wang, H., Ding, P., & Wang, C. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154102 · Cited by 80
Qin, W., Huang, J., Yang, C., Yue, Q., Chen, S., Wang, M., Gao, S., Zhou, X. H., Yang, X., & Zhang, Y. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202209748 · Cited by 80
Insights into the antibacterial mechanism of iron doped carbon dots
Huang, C., Duan, M., Shi, Y., Liu, H., Zhang, P., Zuo, Y., Yan, L., Xu, Y., & Niu, Y. (2023) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2023.04.149 · Cited by 80
An iron age for cancer therapy
Tarangelo, A., & Dixon, S. J. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.199 · Cited by 79
Iron regulatory protein 1 promotes ferroptosis by sustaining cellular iron homeostasis in melanoma
Yao, F., Cui, X., Zhang, Y., Bei, Z., Wang, H., Zhao, D., Wang, H., & Yang, Y. (2021) · Oncology Letters · doi:10.3892/ol.2021.12918 · Cited by 75
Huang, K.-J., Wei, Y., Chiu, Y., Wu, S.-R., & Shieh, D.-B. (2019) · Biomaterials Science · doi:10.1039/c8bm01525b · Cited by 79
Qin, R., Li, S., Qiu, Y., Feng, Y., Liu, Y., Ding, D., Xu, L., Ma, X., Sun, W., & Chen, H. (2022) · Nature Communications · doi:10.1038/s41467-022-29586-w · Cited by 79
Ultraeffective Cancer Therapy with an Antimonene‐Based X‐Ray Radiosensitizer
Duo, Y., Huang, Y., Liang, W., Yuan, R., Li, Y., Chen, T., & Zhang, H. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201906010 · Cited by 77
Population Dynamics in Cell Death: Mechanisms of Propagation
Riegman, M., Bradbury, M. S., & Overholtzer, M. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.07.008 · Cited by 75
Self-citation
Metadata
- Authors
- Kim, S. E., Zhang, L., Ma, K., Riegman, M., Chen, F., Ingold, I., Conrad, M., Turker, M. Z., Gao, M., Jiang, X., Monette, S., Pauliah, M., Gonen, M., Zanzonico, P., Quinn, T., Wiesner, U., Bradbury, M. S., & Overholtzer, M.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Cornell University (US)
- Helmholtz Munich (DE)
- University of Missouri (US)
- Corresponding author
- Bradbury, Michelle S.
- Overholtzer, Michael
- ORCID
- Venue
- Nature Nanotechnology
- Published
- 2016-09-26
- Volume
- 11
- Issue
- 11
- Pages
- 977-985
- ISSN
- 1748-3387 (ISSN-L)
- 1748-3395
- PMC
- PMC5108575
- OpenAlex
- W2527636586
- Cited by
- 622
- References
- 33
- Citations by year
- 2026: 27 · 2025: 52 · 2024: 72 · 2023: 67 · 2022: 89 · 2021: 83 · 2020: 85 · 2019: 56 · 2018: 49 · 2017: 38 · 2016: 2
- FWCI
- 43.24
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Nanotechnology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Site cant be reached (submittedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Funders
- National Institutes of Health (5u54ca199081-05)
- National Cancer Institute (R01CA161280, R01CA166413, U54-CA199081, P30CA008748)
- National Institute of General Medical Sciences (R01GM111350, R01GM113013)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- ferroptosis, ultrasmall nanoparticles, silica nanoparticles, polyethylene glycol coating, nutrient deprivation, cancer cell death, liproxstatin-1, tumor growth inhibition, nanomedicine, tumor xenografts, nanoparticle biodistribution
- MeSH terms
- alpha-MSH, Amino Acids, Animals, Antineoplastic Agents, Humans, Iron, Lysosomes, Melanoma, Particle Size, Polyethylene Glycols, Quinoxalines, Silicon Dioxide, Spiro Compounds, Mice, SCID, Cell Death, Xenograft Model Antitumor Assays, Cell Line, Tumor, Mice, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
